Some speculative mechanisms such as immunomodulatory effects of GLP-1 receptor agonism or indirect effects of significant weight loss on infection susceptibility have been raised in preclinical research, but there is currently no robust human clinical evidence linking these mechanisms to meaningful changes in UTI risk
Wu, J., Kong, M., Lou, Y., Li, L., Yang, C., Xu, H., et al
Long-Term Support for Lasting Results MEDVi isn't just about quick fixes-it's about sustainable change
Clinical Guidance and Prescribing Considerations Prescribing Mounjaro to patients with a single kidney requires a risk-benefit assessment tailored to the individual's clinical context